361 related articles for article (PubMed ID: 26108730)
1. Disturbances in Bone Largely Predict Aortic Calcification in an Alternative Rat Model Developed to Study Both Vascular and Bone Pathology in Chronic Kidney Disease.
Neven E; Bashir-Dar R; Dams G; Behets GJ; Verhulst A; Elseviers M; D'Haese PC
J Bone Miner Res; 2015 Dec; 30(12):2313-24. PubMed ID: 26108730
[TBL] [Abstract][Full Text] [Related]
2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
3. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
Neven E; Vervaet B; Brand K; Gottwald-Hostalek U; Opdebeeck B; De Maré A; Verhulst A; Lalau JD; Kamel S; De Broe ME; D'Haese PC
Kidney Int; 2018 Jul; 94(1):102-113. PubMed ID: 29716795
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol Accelerates Vascular Calcification Irrespective of Vitamin K Status in a Rat Model of Chronic Kidney Disease with Hyperphosphatemia and Secondary Hyperparathyroidism.
McCabe KM; Zelt JG; Kaufmann M; Laverty K; Ward E; Barron H; Jones G; Adams MA; Holden RM
J Pharmacol Exp Ther; 2018 Sep; 366(3):433-445. PubMed ID: 29903718
[TBL] [Abstract][Full Text] [Related]
5. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
[TBL] [Abstract][Full Text] [Related]
6. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy.
Liao HW; Hung PH; Hsiao CY; Liou HH; Lin HS; Huang TH; Jou IM; Tsai KJ
PLoS One; 2015; 10(7):e0133278. PubMed ID: 26186634
[TBL] [Abstract][Full Text] [Related]
9. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
[TBL] [Abstract][Full Text] [Related]
10. Bone Morphogenetic Proteins 2/4 Are Upregulated during the Early Development of Vascular Calcification in Chronic Kidney Disease.
Wei X; Wu W; Li L; Lin J; Liu Q; Gan L; Ou S
Biomed Res Int; 2018; 2018():8371604. PubMed ID: 29850574
[TBL] [Abstract][Full Text] [Related]
11. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
12. Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.
Yu L; Tomlinson JE; Alexander ST; Hensley K; Han CY; Dwyer D; Stolina M; Dean C; Goodman WG; Richards WG; Li X
Calcif Tissue Int; 2017 Dec; 101(6):641-653. PubMed ID: 29038882
[TBL] [Abstract][Full Text] [Related]
13. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.
McCabe KM; Booth SL; Fu X; Shobeiri N; Pang JJ; Adams MA; Holden RM
Kidney Int; 2013 May; 83(5):835-44. PubMed ID: 23344475
[TBL] [Abstract][Full Text] [Related]
14. Mineral bone disorders in chronic kidney disease.
Hou YC; Lu CL; Lu KC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():88-94. PubMed ID: 30298663
[TBL] [Abstract][Full Text] [Related]
15. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
Terai K; Nara H; Takakura K; Mizukami K; Sanagi M; Fukushima S; Fujimori A; Itoh H; Okada M
Br J Pharmacol; 2009 Apr; 156(8):1267-78. PubMed ID: 19302594
[TBL] [Abstract][Full Text] [Related]
16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
17. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
[TBL] [Abstract][Full Text] [Related]
18. Osteogenesis of heterotopically transplanted mesenchymal stromal cells in rat models of chronic kidney disease.
Kramann R; Kunter U; Brandenburg VM; Leisten I; Ehling J; Klinkhammer BM; Knüchel R; Floege J; Schneider RK
J Bone Miner Res; 2013 Dec; 28(12):2523-34. PubMed ID: 23703894
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences.
Shobeiri N; Pang J; Adams MA; Holden RM
J Hypertens; 2013 Jan; 31(1):160-8. PubMed ID: 23183279
[TBL] [Abstract][Full Text] [Related]
20. Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease.
Karamched SR; Nosoudi N; Moreland HE; Chowdhury A; Vyavahare NR
Sci Rep; 2019 Feb; 9(1):2629. PubMed ID: 30796300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
